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Background:  The complete blood count (CBC) is the most widely available laboratory data in the early in-hospital period after ST-elevation 
myocardial infarction (STEMI). We assessed the clinical utility of the combined use of hemoglobin (Hb) level and neutrophil to lymphocyte ratio 
(N/L) for early risk stratification in patients with STEMI.
Methods:  From November 2005 to June 2009, we analyzed 801 consecutive patients with STEMI treated with primary percutaneous coronary 
intervention (PCI) within 12 hours of onset of symptoms. Patients with cardiogenic shock or underlying malignancy were excluded, and 739 patients 
(63 ± 13 years, male 74 %) were included in the final analysis. Patients were categorized into 3 groups by using the median value of N/L (3.86) 
and the presence of anemia (Hb < 13 mg/dl in men and <12 mg/dl in women): group I, low N/L & no anemia (n=272); group II, no group I or III 
(n=331); group III, high N/L & anemia (n=136).
Results:  There were significant differences on clinical outcomes during 6-month follow-up among 3 groups: 16%, 18% and 29% of in-hospital 
complication (p<0.001), 3%, 7% and 14% of 1 month composite major cardiac events (p<0.001), and 1%, 7% and 14% of 6 month deaths 
(p<0.001) occurred from group 1 to 3, respectively. The prognostic discriminatory capacity of the combined use of Hb level and N/L was also 
significant in high-risk subgroups, such as patients with an advanced age, diabetes mellitus, multivessel coronary disease, low ejection fraction, and 
even in those having higher mortality risk based on the TIMI risk score. In a Cox proportional hazard model, after adjusting for multiple covariates, 
group III had higher mortality at 6 months (hazard ratio 5.6, 95% confidence interval 1.1 to 27.9; p = 0.036) compared with group I.
Conclusions:  The combined use of Hb level and N/L, which are readily available CBC data in the early in-hospital period, provides valuable timely 
information for early risk stratification in patients with STEMI undergoing primary PCI.
